NCT01424527View on ClinicalTrials.gov

Korean Chronic Obstructive Pulmonary Disease(COPD) Assessment Test Validation Study

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Pulmonary Disease, Chronic Obstructive
Trial Locations (5)

431-070

GSK Investigational Site, Anyang-si

Unknown

GSK Investigational Site, Busan

GSK Investigational Site, Gyung Gi Do

GSK Investigational Site, Incheon

GSK Investigational Site, Seoul

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01424527 - Korean Chronic Obstructive Pulmonary Disease(COPD) Assessment Test Validation Study | Biotech Hunter | Biotech Hunter